NCT01737762 - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 | Biotech Hunter

Enrollment

155

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Venous Leg Ulcers

Interventions

BIOLOGICAL

HP802-247

HP802-247 (fibrinogen solution \& thrombin solution containing living, irradiated, growth arrested keratinocytes and fibroblasts) 260 µL (130 µL, one spray, of each solution) containing 0.5 x106 cells per mL every 14 days.

BIOLOGICAL

Vehicle

Trial Locations (43)

10025

New York

11554

East Meadow

18512

Dunmore

19610

Wyomissing

20007

Washington D.C.

21224

Baltimore

27599

Chapel Hill

33013

Hialeah

33125

Miami

33143

South Miami

37909

Knoxville

44094

Willoughby

44307

Akron

48602

Saginaw

60611

Chicago

62650

Jacksonville

62702

Springfield

63090

Washington

74127

Tulsa

76107

Fort Worth

85006

Phoenix

85012

Phoenix

85015

Phoenix

89119

Las Vegas

90095

Los Angeles

90822

Long Beach

91342

Sylmar

92009

Carlsbad

92013

San Diego

92653

Laguna Hills

93720

Fresno

94546

Castro Valley

95608

Fair Oaks

98431

Tacoma

02118

Boston

07002

Bayonne

07030

Hoboken

T2T5C7

Calgary

R3A1R9

Winnipeg

L8R2R3

Hamilton

N6C5J1

London

J1H5N4

Sherbrooke

00909-1711

San Juan